Retraction
m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling
Paper Information
Record ID:
37381
Author(s):
Journal:
Publication Date:
June 24, 2021
Retraction Date:
May 04, 2022
(3.5 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (26)
26
Total Citations19
Post-Retraction(73.1%)
7
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
12
Within 1 year
4
After 2+ years
1113
Days since retraction (latest)
CALB2 facilitates macrophage M2 polarization to promote the growth and metastasis of pancreatic adenocarcinoma
Dongwei Hu, Bo Xu, Guoyu Huang et al. (8 authors)
Cellular Signalling
Published: May 2025
1113 days after retraction
FTO/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12
Zuyao Chen, Xiaolin Zhong, Min Xia et al. (11 authors)
Cell Death and Disease
Open Access
Published: Oct 2024
2 citations
2 citations
888 days after retraction
The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression
Liushan Wei, Shun Liu, Zhizhong Xie et al. (6 authors)
International Immunopharmacology
Published: Aug 2024
1 citation
1 citation
826 days after retraction
WTAP/IGF2BP3-mediated GBE1 expression accelerates the proliferation and enhances stemness in pancreatic cancer cells via upregulating c-Myc
Weiwei Jin, Yanru Yao, Yuhan Fu et al. (10 authors)
Cellular & Molecular Biology Letters
Open Access
Published: Jul 2024
5 citations
5 citations
791 days after retraction
RNA N6-methyladenosine demethylase FTO targets MOXD1 promoting the malignant phenotype of gastric cancer
Yuexing Lai, Hairong Dong, Ping Xu et al. (7 authors)
BMC Gastroenterology
Open Access
Published: Jan 2024
2 citations
2 citations
616 days after retraction
FTO-Mediated lncRNA-FNDRR Axis Demethylation Promotes Cell Proliferation, Invasion, and Migration in Esophageal Squamous Cell Carcinoma
Xuyang Liang, Libo Wang, Lu Wang et al. (8 authors)
Journal of Biomedical Nanotechnology
Published: Jul 2023
423 days after retraction
FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination
Songbai Liu, Peng Liu, Changhao Zhu et al. (11 authors)
Aging
Open Access
Published: Jun 2023
6 citations
6 citations
413 days after retraction
Epigenetic reprogramming in pancreatic premalignancy and clinical implications
Wei Zhang, Tingting Jiang, Keping Xie
Frontiers in Oncology
Open Access
Published: Feb 2023
4 citations
4 citations
288 days after retraction
The Emerging Role of m6A Modification in Endocrine Cancer
Xiaoyu Ji, Zhiyuan Wang, Wei Sun et al. (4 authors)
Cancers
Open Access
Published: Feb 2023
6 citations
6 citations
278 days after retraction
The emerging roles of epitranscriptomic marks in cancer
Mirolyuba Ilieva, Sakari Kauppinen, Shizuka Uchida et al. (4 authors)
Elsevier eBooks
Published: Jan 2023
242 days after retraction
Role of N<sup>6</sup>‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
Tong Ye, Jiaxin Wang, Haiying Zhao et al. (5 authors)
International Journal of Oncology
Open Access
Published: Nov 2022
3 citations
3 citations
190 days after retraction
Prognostic and clinicopathological value of m6A regulators in human cancers: a meta-analysis
Zhangci Su, Leyao Xu, Xinning Dai et al. (10 authors)
Aging
Open Access
Published: Nov 2022
7 citations
7 citations
187 days after retraction
METTL3-IGF2BP3-axis mediates the proliferation and migration of pancreatic cancer by regulating spermine synthase m6A modification
Zhenyun Guo, Xiang Zhang, Chengjie Lin et al. (8 authors)
Frontiers in Oncology
Open Access
Published: Oct 2022
22 citations
22 citations
155 days after retraction
The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma
Dalin Zhang, Sarah Wornow, Donna M. Peehl et al. (5 authors)
Translational Oncology
Open Access
Published: Aug 2022
10 citations
10 citations
115 days after retraction
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu et al. (7 authors)
Experimental Hematology and Oncology
Open Access
Published: Aug 2022
158 citations
158 citations
97 days after retraction
<scp>N<sup>6</sup></scp>‐methyladenosine <scp>RNA</scp> demethylase <scp>FTO</scp> regulates extracellular matrix‐related genes and promotes pancreatic cancer cell migration and invasion
Wei Wang, Ying He, Lun Wu et al. (8 authors)
Cancer Medicine
Open Access
Published: Jul 2022
10 citations
10 citations
82 days after retraction
The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
Xiaoge Hu, Xiangxiang Lei, Jinhui Guo et al. (9 authors)
Frontiers in Oncology
Open Access
Published: Jul 2022
6 citations
6 citations
79 days after retraction
Research advances of <scp>N6</scp>‐methyladenosine in diagnosis and therapy of pancreatic cancer
Sai Chen, Hefei Ren, Xiaomin Zhang et al. (9 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Jul 2022
18 citations
18 citations
72 days after retraction
Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer
Xiaolin Qu, Yongqiu Zhang, Xianzheng Sang et al. (6 authors)
Cancers
Open Access
Published: Jun 2022
11 citations
11 citations
56 days after retraction
FTO m6A Demethylase in Obesity and Cancer: Implications and Underlying Molecular Mechanisms
Sarah Kassem Azzam, Habiba Alsafar, Abdulrahim A. Sajini
International Journal of Molecular Sciences
Open Access
Published: Mar 2022
128 citations
128 citations
35 days before retraction
FTO in cancer: functions, molecular mechanisms, and therapeutic implications
Yangchan Li, Rui Su, Xiaolan Deng et al. (5 authors)
Trends in cancer
Open Access
Published: Mar 2022
153 citations
153 citations
40 days before retraction
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan et al. (11 authors)
Molecular Cancer
Open Access
Published: Feb 2022
281 citations
281 citations
79 days before retraction
Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner
Zhenyu Wang, Huamin Sun, Hua Zhu et al. (8 authors)
TURKISH JOURNAL OF BIOLOGY
Open Access
Published: Jan 2022
5 citations
5 citations
123 days before retraction
Novel insights into m<sup>6</sup>A modification of coding and non-coding RNAs in tumor biology: From molecular mechanisms to therapeutic significance
Jinlin Jia, Suwen Wu, Zimo Jia et al. (9 authors)
International Journal of Biological Sciences
Open Access
Published: Jan 2022
17 citations
17 citations
123 days before retraction
m<sup>6</sup>A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism
Peihua Liu, Benyi Fan, Belaydi Othmane et al. (9 authors)
Theranostics
Open Access
Published: Jan 2022
51 citations
51 citations
123 days before retraction
Effect of demethyltransferase FTO on tumor progression
LING SHENG, Yuehong Shen, Hongyu Yang
Biocell
Open Access
Published: Jan 2022
123 days before retraction
Quick Stats
Total Citations:
26
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025